Enovis to Participate in the 2026 Wells Fargo Healthcare Conference
Enovis (NYSE: ENOV) announced it will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at Encore Boston Harbor.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Enovis (NYSE: ENOV) announced it will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at Encore Boston Harbor. CEO Damien McDonald and CFO Ben Berry will join a fireside chat at 1:30 p.m. Eastern Time. A live audio webcast and replay will be accessible through the company’s website under the Investors > Events and Presentations section.
Details
News Market Reaction – ENOV
On Sep 1, the first trading day after this news, ENOV closed 16.51% below the previous close. Argus tracked a trough of -12.7% from its starting point during tracking. Our momentum scanner recorded 106 alerts for this stock that day. Relative volume reached 5.8x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 1 session.
Key Figures
- Conference date
- September 8, 2026
- 2026 Wells Fargo HealthCare conference
- Fireside chat time
- 1:30 p.m. Eastern Time
- September 8, 2026 event
Historical Context
-
Reported Q2 sales growth, margin improvement, and reaffirmed 2026 guidance
-
Announced Q2 results call logistics ahead of scheduled August 6 reporting
-
U.S. launch of CT-RevitL veterinary photobiomodulation laser therapy system
-
Launched hybrid scoliosis brace with corrective elements and adjustable vest
-
Reported Q1 sales growth, adjusted EBITDA, and reaffirmed full-year guidance
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Dallas, TX, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will participate in the 2026 Wells Fargo HealthCare conference on Tuesday, September 8, 2026 at the Encore Boston Harbor.
Damien McDonald, Chief Executive Officer, and Ben Berry, Chief Financial Officer, will participate in a fireside chat session at 1:30 p.m. Eastern Time. A link to the live audio webcast, as well as a replay of the event, will be available on the Company’s website under the Investors tab at Events and Presentations.
About Enovis
Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com and follow us on Facebook, Instagram, LinkedIn and X.
Investor Contact
Kyle Rose, Vice President, Investor Relations
investorrelations@enovis.com
Media Contact
Rachel Colloff, Sr. Director, Corporate Communications
Rachel.Colloff@enovis.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.